Trade Names: | |
Synonyms: | |
Status: | Approved (2019) |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
ATC: | N04CX01 |
UNII: | 2GZ0LIK7T4 |
InChI Key | IQVRBWUUXZMOPW-PKNBQFBNSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C20H24N4O4 |
Molecular Weight | 384.44 |
AlogP | 2.12 |
Hydrogen Bond Acceptor | 8.0 |
Hydrogen Bond Donor | 0.0 |
Number of Rotational Bond | 6.0 |
Polar Surface Area | 80.28 |
Molecular species | NEUTRAL |
Aromatic Rings | 3.0 |
Heavy Atoms | 28.0 |
Action | Mechanism of Action | Reference |
---|---|---|
ANTAGONIST | Adenosine A2a receptor antagonist | PubMed |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C9
|
- | 13000 | - | - | - | |
Enzyme
Oxidoreductase
|
- | - | - | 27 | - | |
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Nucleotide-like receptor (family A GPCR)
Adenosine receptor
|
- | 5248-5250 | 1259 | 2-200 | 47 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Liver Diseases | 1 | D008107 | ClinicalTrials |
Substance-Related Disorders | 1 | D019966 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 155270-99-8 |
ChEBI | 134726 |
ChEMBL | CHEMBL431770 |
DrugBank | DB11757 |
DrugCentral | 4882 |
EPA CompTox | DTXSID7057652 |
FDA SRS | 2GZ0LIK7T4 |
Guide to Pharmacology | 5608 |
PubChem | 5311037 |
SureChEMBL | SCHEMBL633262 |
ZINC | ZINC000003803921 |